# Verona Pharma plc: Form D filings

Verona Pharma plc, a pharmaceuticals company in London, United Kingdom, filed 2 Form D notices with the SEC between 2016 and 2020. The latest, on July 30, 2020, reports $200.2 million sold of a $200.2 million offering to 43 investors.

Find out what Verona Pharma plc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Verona%20Pharma%20plc%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Verona%20Pharma%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fverona-pharma-plc-1657312)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Verona%20Pharma%20plc%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Verona%20Pharma%20plc&page=%2Fdata%2Fform-d%2Fcompany%2Fverona-pharma-plc-1657312)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals
- [Form D filings](https://specstream.ai/data/form-d): 44,302 rows, by operating companies, filed since November 1, 2024, $523.02, or the new rows each week for $92.05 a month. Buy: https://specstream.ai/data/form-d

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 3 More London Riverside, London, United Kingdom, SE1 2
- Phone: 011-44-0-2032834200
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: United Kingdom
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1657312

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jul 30, 2020 | New notice | $200,155,041 | $200,155,041 | $0 | 43 | Jul 22, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1657312/000156761920013888/0001567619-20-013888-index.htm) |
| Jul 20, 2016 | New notice | $44,524,058 | $44,524,058 | $0 | 8 | Jun 17, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1657312/000165731216000001/0001657312-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Andrew W. Sinclair | Director |  |
| Mahendra W. Shah | Director |  |
| Rishi W. Gupta | Director |  |
| David W. Ebsworth | Director |  |
| Mark W. Hahn | Executive Officer |  |
| Kathleen W. Rickard | Executive Officer |  |
| Anders W. Ullman | Director |  |
| Claire W. Poll | Executive Officer |  |
| Martin W. Edwards | Director |  |
| Ken W. Cunningham | Director |  |
| David Zaccardelli | Executive Officer, Director |  |
| Vikas W. Sinha | Director |  |

[Every Form D from the week of Jul 27, 2020](https://specstream.ai/data/form-d/week/2020-07-27) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Verona Pharma plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).